[1]白 璐.辅助应用疏血通注射液对急性心肌梗死患者凝血指标及心电图变化的影响[J].医学信息,2022,35(02):172-174.[doi:10.3969/j.issn.1006-1959.2022.02.045]
　BAI Lu.Effect of Shuxuetong Injection on Coagulation Index and Electrocardiogram Changesin Patients with Acute Myocardial Infarction[J].Medical Information,2022,35(02):172-174.[doi:10.3969/j.issn.1006-1959.2022.02.045]
点击复制

辅助应用疏血通注射液对急性心肌梗死患者凝血指标及心电图变化的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年02期
页码:
172-174
栏目:
中医中药
出版日期:
2022-01-15

文章信息/Info

Title:
Effect of Shuxuetong Injection on Coagulation Index and Electrocardiogram Changesin Patients with Acute Myocardial Infarction
文章编号:
1006-1959（2022）02-0172-03
作者:
白 璐
天津市中医药研究院附属医院药剂科，天津 300120
Author(s):
BAI Lu
Department of Pharmacy,Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital,Tianjin 300120,China
关键词:
疏血通注射液; 急性心肌梗死; 凝血指标; 心电图
Keywords:
Shuxuetong injection; Acute myocardial infarction; Coagulation index; Electrocardiogram
分类号:
R542.2+2
DOI:
10.3969/j.issn.1006-1959.2022.02.045
文献标志码:
A
摘要:
目的 研究辅助应用疏血通注射液对急性心肌梗死患者凝血指标及心电图变化的影响。方法 选取2020年1月-12月在我院接受治疗的120例急性心肌梗死患者为研究对象，采用随机数字表法分为对照组和观察组，各60例。对照组采用美托洛尔治疗，观察组在对照组基础上辅助应用疏血通注射液治疗。比较两组临床治疗总有效率、凝血功能、心功能、心电图QTd、血浆脑钠肽（BNP）以及临床不良反应发生情况。结果 观察组总有效率为91.67%，高于对照组的71.67%（P＜0.05）；观察组血浆凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）凝血酶时间（TT）较对照组长，纤维蛋白原（Fbg）低于对照组（P＜0.05）；观察组射血分数（EF）、心脏指数（CI）、搏动量（SV）、心排出量（CO）均高于对照组（P＜0.05）；两组QTd及BNP均低于治疗前，且观察组低于对照组（P＜0.05）；观察组不良反应发生率为5.00%，与对照组的6.67%比较，差异无统计学意义（P＞0.05）。结论 辅助应用疏血通注射液治疗急性心肌梗死可提高总有效率，改善凝血功能和心功能，促进心电图指标恢复，且不会增加临床不良反应，是一种安全、有效辅助用药。
Abstract:
Objective To study the effect of Shuxuetong injection on coagulation index and electrocardiogram changes in patients with acute myocardial infarction.Methods A total of 124 patients with acute myocardial infarction treated in our hospital from January to December 2020 were selected and randomly divided into control group and observation group, with 60 cases in each group. The control group was treated with metoprolol, and the observation group was treated with Shuxuetong injection on the basis of the control group. The total effective rate, coagulation function, cardiac function, electrocardiogram QTd ,plasma brain natriuretic peptide (BNP) and clinical adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 91.67%, which was higher than 71.67% of the control group (P<0.05).The plasma prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) of the observation group were longer than those of the control group, and fibrinogen (Fbg) was lower than that of the control group (P<0.05).The ejection fraction (EF), cardiac index (CI), pulse volume (SV) and cardiac output (CO) in the observation group were higher than those in the control group (P<0.05); QTd and BNP in the two groups were lower than those before treatment, and those in the observation group were lower than the control group (P<0.05).The incidence of adverse reactions in the observation group was 5.00%, which was compared with 6.67% in the control group, the difference was not statistically significant (P>0.05).Conclusion The adjuvant application of Shuxuetong injection in the treatment of acute myocardial infarction can improve the total effective rate, improve coagulation function and cardiac function, promote the recovery of electrocardiogram indexes, and does not increase clinical adverse reactions. It is a safe and effective adjuvant drug.

参考文献/References:

[1]邓丽玉,林彬,涂胜,等.缺氧诱导因子对急性心肌梗死后心肌细胞及细胞外基质的影响[J].国际心血管病杂志,2016,43(1):43-45,59.[2]李瑞,樊振.疏血通注射液对急诊室急性ST段抬高型心肌梗死患者血流变学水平的影响[J].辽宁中医杂志,2019,11(12):128-131.[3]马文洁,袁自华,李桂花.替罗非班给药方式对ST段抬高急性心肌梗死PCI后心功能和预后影响及机制研究[J].心电图杂志(电子版),2020,9(3):414-415.[4]陆卫红,黄勇先,朱晓明.冠脉血液凝血状态对急性心肌梗死患者症状改善和心功能的影响[J].齐齐哈尔医学院学报,2019,40(17):2155-2157.[5]张思灵.美托洛尔联合莫雷西嗪治疗冠心病心律失常的效果[J].河南医学研究,2019,28(2):304-305.[6]王爱,王成德.脑心通胶囊对急性心肌梗死患者PCI后心肌灌注和血小板活化功能的影响[J].中国药房,2016,27(27):3800-3801,3802.[7]丁栗.中西医结合疗法对急性心肌梗死患者微循环与血小板状态的影响研究[J].世界中西医结合杂志,2016,11(3):368-371.[8]吴波.疏血通注射液对脑梗死患者血流变及微循环状态的影响[J].中国实用神经疾病杂志,2016,19(11):57-59.[9]张彩霞,余晓峰,刘杰祥.疏血通注射液联合瑞舒伐他汀治疗急性心肌梗死后心绞痛的临床观察[J].中国药房,2018,29(2):216-219.[10]刘春霄,王宇彤,郭长义.疏血通注射液对急性心肌梗死患者左心室重构和心功能的影响[J].现代中西医结合杂志,2016,25(16):1758-1760.[11]张晶晶,杨瑞.疏血通注射液对急性心肌梗死患者的疗效及对微循环及血小板状态的影响研究[J].世界中医药,2017,12(7):1540-1543.[12]肖姗姗,张思雯,刘吉伟,等.瑞替普酶与尿激酶治疗急性心肌梗死的临床疗效[J].中西医结合心脑血管病杂志,2017,15(23):3021-3023.[13]金洪珍,张盼.氯吡格雷联合阿司匹林治疗急性心肌梗死的临床疗效观察[J].山西医药杂志,2017,46(21):2629-2631.[14]齐献忠,邢英瀛,张小林.疏血通注射液联合尼麦角林治疗急性脑梗死的临床研究[J].现代药物与临床,2019,34(6):1683-1687.[15]李朝晖,周元锋,田峰,等.高压氧联合阿司匹林治疗急性心肌梗死的临床疗效及对血清炎性因子水平的影响[J].中华航海医学与高气压医学杂志,2019,26(3):248-251.[16]孟斌,王胜.大剂量瑞舒伐他汀联合疏血通注射液对不稳定型心绞痛患者血清HIF-1α、sCD40L水平变化的影响[J].武警医学,2018,29(6):582-585,590.[17]谭朝阳,刘大伟.疏血通注射液对急性心肌梗死患者相关指标的影响[J].中国药房,2017,28(24):3374-3376.[18]侯凌波,李论,成忠.美托洛尔对慢性阻塞性肺疾病合并急性心肌梗死患者心肺功能和心血管不良事件的影响[J].临床心血管病杂志,2019,35(6):513-517.[19]逯豫霞,白玉茹,李劭凝,等.生脉注射液联合阿替普酶治疗急性心肌梗死的临床研究[J].现代药物与临床,2016,31(5):615-618.[20]刘金柱,袁相秋,朱刚聚.疏血通注射液对急性心肌梗死患者心功能和内皮功能的影响[J].中西医结合心脑血管病杂志,2016,13(4):544-545.

相似文献/References:

[1]郭建华.丹参川芎嗪联合阿托伐他汀钙治疗急性心肌梗死的疗效观察[J].医学信息,2018,31(01):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
　GUO Jian-hua.Effect of Salvia Miltiorrhiza Tetramethylpyrazine Combined with Atorvastatin Calcium in the Treatment of Acute Myocardial Infarction[J].Medical Information,2018,31(02):145.[doi:10.3969/j.issn.1006-1959.2018.01.056]
[2]余湘宁,赵献明.ECMO在危重症心脏疾病中的应用研究[J].医学信息,2018,31(04):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
　YU Xiang-ning,ZHAO Xian-ming.Study on the Application of ECMO in Critical Heart Disease[J].Medical Information,2018,31(02):38.[doi:10.3969/j.issn.1006-1959.2018.04.013]
[3]王 娟.疏血通联合马来酸桂哌齐特治疗视网膜中央动脉阻塞的 疗效观察[J].医学信息,2018,31(06):120.[doi:10.3969/j.issn.1006-1959.2018.06.040]
　WANG Juan.Clinical Observation of Shuxuetong Combined with Cinepazide Maleate in the Treatment of Central Retinal Artery Occlusion[J].Medical Information,2018,31(02):120.[doi:10.3969/j.issn.1006-1959.2018.06.040]
[4]何 丽.应激性高血糖与急性心肌梗死的机制研究[J].医学信息,2022,35(10):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
　HE Li.Mechanism of Stress Hyperglycemia and Acute Myocardial Infarction[J].Medical Information,2022,35(02):74.[doi:10.3969/j.issn.1006-1959.2022.10.018]
[5]毛红岩,宁国贤.冠脉介入治疗对冠心病急性心肌梗死患者 心肌损伤及心室重塑的影响[J].医学信息,2018,31(12):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
　MAO Hong-yan,NING Guo-xian.Effects of Coronary Intervention on Myocardial Injury and Ventricular Remodeling in Patients with Coronary Heart Disease and Acute Myocardial Infarction[J].Medical Information,2018,31(02):102.[doi:10.3969/j.issn.1006-1959.2018.12.031]
[6]雷 锐,李 志.冠状动脉介入及替罗非班治疗老年急性心肌梗死并 心源性休克的疗效分析[J].医学信息,2018,31(14):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
　LEI Rui,LI Zhi.Effect of Coronary Intervention and Tirofiban on Elderly Patients with Acute Myocardial Infarction and Cardiogenic Shock[J].Medical Information,2018,31(02):150.[doi:10.3969/j.issn.1006-1959.2018.14.046]
[7]高 鹏,林文华,敬 锐,等.红细胞压积变化对急性ST段抬高型心肌梗死患者临床预后的影响[J].医学信息,2019,32(03):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
　GAO Peng,LIN Wen-hua,JING Rui,et al.Effect of Hematocrit Changes on Clinical Prognosis in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Medical Information,2019,32(02):78.[doi:10.3969/j.issn.1006-1959.2019.03.024]
[8]高 珍,刘重斌,张菊英.氧疗对急性心肌梗死患者预后的影响[J].医学信息,2018,31(18):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
　GAO Zhen,LIU Chong-bin,ZHANG Ju-ying.Effect of Oxygenic Therapy on Prognosis of Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.18.011]
[9]韩 宇,朱丽丽,孙 婷,等.急性心肌梗死患者排便意愿的调查研究[J].医学信息,2018,31(20):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
　HAN Yu,ZHU Li-li,SUN Ting,et al.Investigation of Defecation Intention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(02):111.[doi:10.3969/j.issn.1006-1959.2018.20.033]
[10]陈笑玲.急救护理流程再造在急性心肌梗死急诊介入治疗中的作用观察[J].医学信息,2018,31(23):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]
　CHEN Xiao-ling.Effect of Emergency Nursing Process Reengineering on Emergency Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction[J].Medical Information,2018,31(02):168.[doi:10.3969/j.issn.1006-1959.2018.23.049]

更新日期/Last Update: 1900-01-01